Unclassified

[Comment] Combination therapy in metabolic dysfunction-associated steatohepatitis | ClinicLens

Metabolic dysfunction-associated steatotic liver disease and its progressive form, metabolic dysfunction-associated steatohepatitis, are multisystem disorders in which metabolic, inflammatory, and fibrogenic pathways converge to cause liver injury. Therapy previously focused on l

Medical Literature · Updated

← Back to articles
This standalone article is served from the ClinicLens content archive.

If the embedded page does not load in your browser, open it directly.